- More than 10 million people globally have Parkinson’s disease.
- There is currently no cure for Parkinson’s disease.
- For a few years, researchers have been looking at the energy molecule nicotinamide adenine dinucleotide (NAD+) as a possible treatment for the condition.
- A phase 1 clinical trial has found a high dose supplementation of NR, a form of vitamin B3, helps increase NAD+ levels in people with Parkinson’s disease.
- The NR supplementation may be associated with clinical symptom improvement of Parkinson’s disease.
Researchers estimate that more than 10 million people around the world have Parkinson’s disease, making it the second most prevalent neurodegenerative disease after Alzheimer’s disease.
There is currently no cure for Parkinson’s disease. Medications,
Over the past few years, researchers have also looked at nicotinamide adenine dinucleotide (NAD+) — an important molecule that helps the body create energy — as a possible treatment for Parkinson’s disease.
Previous research suggests people with Parkinson’s may have a
Now, a phase 1 clinical trial has found that a high dose supplementation of
The study was recently published in the journal
According to Prof. Charalampos Tzoulis, professor of neurology and neurogenetics at the University of Bergen and Haukeland University Hospital, Bergen Norway, and co-lead author of this study, NR is a form of vitamin B3 and a precursor of NAD+.
“NAD+ is an essential coenzyme that plays a vital role in multiple cellular processes,…
Read the full article here